Our Company

30 years of innovation in immunotherapy

According to the World Health Organization (WHO), immunotherapy is the only treatment option that addresses the underlying cause of allergy and can modify the natural course of allergic disease while significantly reducing or eliminating allergic symptoms.

Who are we?
We are an international pharmaceutical company focused on the R&D
of allergen immunotherapy products.
Get to know us
Milestones
Our milestones are an indication of our unwavering determination to move forward into the future.
Our History
Contact
Please fill out the contact form for your inquiries.
Contact Form

Professional user area

ROXALL Group

You can change your location and language preferences based on the country you are interested in.